In order to strengthen its scientific knowledge base and increase the visibility of its innovative technology in the treatment of autoimmune diseases in the scientific community, Neovacs has assembled an international Scientific Committee. This committee is composed of leading world experts in the fields of immune therapy, chronic inflammatory and autoimmune diseases.
Their mission is to advise the company on its therapeutic targets applicable to the Kinoid® technology and addressing unmet medical needs.
Pr. Jacques Banchereau, PhD
Chairman of Neovacs Scientific advisory board
Professor and Director of Immunological Sciences, Jackson Laboratory for Genomic Medicine et Baylor Institute for Immunology Research Farmingtown, Connecticut, USA.
Dr. Virginia Pascual, MD
Director of the Gale and Ira Drukier Institute for Children’s Health, New York, USA
Pediatric Rheumatologist specializing in lupus and chronic autoimmune diseases. Dr. Pascual has been instrumental in discovering some of the underlying mechanisms of the lupus disease, such as identifying the role of interferon alpha.
Pr. Bernard Lauwerys, MD, PhD
Rheumatologist specializing chronic autoimmune diseases (lupus).at Cliniques Universitaires Saint Luc & Université Catholique de Louvain, Belgium.
Pr. Miriam Merad, MD, PhD
Professor of Oncological Sciences, Medicine and Immunology at Tisch Cancer Institute , Icahn School of Medicine at Mount Sinai, New York.
Pr. Laurence Zitvogel, MD, PhD
Director of INSERM U1015, Head of Dpt. Of Cancer Immunology and Immunotherapy at Institut Gustave Roussy, Paris, France.
3-5, Impasse Reille
Tel. : 33 (0)1 53 10 93 00
Fax : 33 (0)1 53 10 93 03
POURQUOI INVESTIR ?VOIR L’ESPACE INVESTISSEURS